SCS Traditional denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for scs traditional are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Traditional Spinal Cord Stimulation as Not FDA-Approved

A not-FDA-approved denial for traditional spinal cord stimulation (SCS) from UnitedHealthcare most commonly occurs in one of three scenarios: (1) the specific device system or lead configuration requested has not received FDA clearance or approval for the stated indication; (2) the indication documented in the prior authorization request does not match the device's cleared intended use; or (3) the denial is issued in error because the reviewer applied an incorrect regulatory standard. Understanding which scenario applies is the first step in building your appeal.

## Why This Denial Is Appealable

Implantable SCS systems that have received FDA clearance (510(k)) or approval (PMA) for chronic intractable pain of the trunk and/or limbs are not unapproved devices. If the system your physician requested holds FDA clearance for an indication that matches your diagnosis, this denial is factually incorrect on its face and should be overturned. Even where a newer stimulation waveform or lead design is involved, many have received their own separate FDA clearances. Identifying the exact regulatory status of the specific device and indication is the foundation of your appeal.

## Federal Appeal Framework

• Internal appeal (ACA §2719 / ERISA §503): File within your denial letter's deadline. The appeal should open by producing the FDA clearance documentation for the specific device and stating clearly that the predicate for the denial — that the device lacks FDA approval — is factually incorrect.
• External review: If internal appeal is unsuccessful, escalate to independent external review. An independent clinician reviewing FDA clearance documents and your chart is well-positioned to overturn a denial premised on a regulatory mischaracterization.
• Expedited review: Available for urgent situations.
• Regulatory complaint: If UHC persists in characterizing an FDA-cleared device as unapproved, a complaint to your state insurance commissioner is appropriate — misrepresenting a device's regulatory status in a coverage denial may constitute a bad-faith claims practice.

## Documentation to Gather

• FDA clearance or approval document: The specific 510(k) summary or PMA approval order for the SCS device being requested, obtained from the FDA's public device database (accessdata.fda.gov) or from the device manufacturer.
• Indication match documentation: A letter from your implanting physician confirming that the planned use of the device falls within its FDA-cleared indication, using the exact language of the clearance.
• Device labeling: The FDA-approved labeling (Instructions for Use) for the requested device, showing the cleared indications.
• Diagnosis confirmation: Chart notes, imaging, and clinical documentation establishing your diagnosis and its alignment with the cleared indication.
• Prescriber letter: A cover letter from your physician summarizing the regulatory status, your diagnosis, and why the denial's factual premise is incorrect.

## Criteria-Mapping Structure

Obtain UHC's coverage policy for spinal cord stimulation. Identify the specific language the plan cites as the basis for the not-approved determination. Your appeal letter should quote that language and then provide the FDA clearance documentation that directly contradicts it — device name, clearance number, cleared indication, and date of clearance — with a statement from your physician mapping your diagnosis to the cleared use.